Sponsor or institution

Clinical trials and research at Kedrion S.p.A.

• 2Clinical trials
• 8Countries

All recruiting trials (2)

• Intravenous 10% Human Immunoglobulin (KIg10) for Adults with Chronic ITP

  This trial will test whether KIg10 (intravenous human normal immunoglobulin 10%) can raise platelet counts and is safe for adults with chronic primary ITP who have low platelets.

  Recruiting at 25 sites Phase 3 Kedrion S.p.A. · Los Angeles, California and 27 other locations · NCT07059000

• KIg10 (intravenous human immune globulin 10%) maintenance therapy for CIDP

  This trial will test whether two different maintenance doses of IV immune globulin (KIg10), given every three weeks, help adults with CIDP stay stable and avoid worsening.

  Recruiting at 6 sites Phase 3 Kedrion S.p.A. · Stamford, Connecticut and 5 other locations · NCT06752356

Quick answers

How many clinical trials run by Kedrion S.p.A. are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 8 countries. The most sites are in United States (2 trials), Czechia (1 trial), Germany (1 trial), Italy (1 trial), Romania (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 3: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →